Cargando…

Synthetic nanobody–SARS-CoV-2 receptor-binding domain structures identify distinct epitopes

The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands unprecedented attention. We report four X-ray crystal structures of three synthetic nanobodies (sybodies) (Sb16, Sb45 and Sb68) bind to the receptor-binding domain (RBD) of SARS-CoV-2: binary complexes of Sb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Javeed, Jiang, Jiansheng, Boyd, Lisa F., Natarajan, Kannan, Margulies, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852268/ https://www.ncbi.nlm.nih.gov/pubmed/33532775 http://dx.doi.org/10.1101/2021.01.27.428466

Ejemplares similares

Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
por: Ahmad, Javeed, et al.
Publicado: (2021)

SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
por: Jiang, Jiansheng, et al.
Publicado: (2023)

SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
por: Jiang, Jiansheng, et al.
Publicado: (2023)

Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
por: Ahmad, Javeed, et al.
Publicado: (2021)

Chaperone function in antigen presentation by MHC class I molecules—tapasin in the PLC and TAPBPR beyond
por: Margulies, David H., et al.
Publicado: (2023)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Chaperones and Catalysts: How Antigen Presentation Pathways Cope With Biological Necessity
por: Margulies, David H., et al.
Publicado: (2022)

Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
por: Pymm, Phillip, et al.
Publicado: (2022)

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
por: Dormeshkin, Dmitri, et al.
Publicado: (2022)

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
por: Stefan, Maxwell A., et al.
Publicado: (2021)

Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
por: Longsompurana, Phoomintara, et al.
Publicado: (2023)

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
por: Schoof, Michael, et al.
Publicado: (2020)

Structural mechanism of tapasin-mediated MHC-I peptide loading in antigen presentation
por: Jiang, Jiansheng, et al.
Publicado: (2022)

The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
por: Zebardast, Arghavan, et al.
Publicado: (2021)

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
por: Ma, Huan, et al.
Publicado: (2021)

Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice
por: Liu, Song, et al.
Publicado: (2022)

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
por: Custódio, Tânia F., et al.
Publicado: (2020)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron
por: Casasnovas, José M., et al.
Publicado: (2022)

Nanobody derived using a peptide epitope from the spike protein receptor-binding motif inhibits entry of SARS-CoV-2 variants
por: Mendon, Nivya, et al.
Publicado: (2022)

A Murine CD8(+) T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Yang, Jihyun, et al.
Publicado: (2021)

Targeting Ras-binding domain of ELMO1 by computational nanobody design
por: Tam, Chunlai, et al.
Publicado: (2023)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation
por: Schoof, Michael, et al.
Publicado: (2020)

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Li, Tingting, et al.
Publicado: (2021)

Structural Insights into the Design of Synthetic Nanobody Libraries
por: Valdés-Tresanco, Mario S., et al.
Publicado: (2022)

Generation of Synthetic Acinetobacter baumannii-Specific Nanobodies
por: Knauf, Gregory A., et al.
Publicado: (2023)

Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2
por: Huang, Kuan-Ying A., et al.
Publicado: (2023)

An allosteric site in the T-cell receptor Cβ domain plays a critical signalling role
por: Natarajan, Kannan, et al.
Publicado: (2017)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
por: Modhiran, Naphak, et al.
Publicado: (2023)

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
por: Yuan, Meng, et al.
Publicado: (2020)

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
por: Esparza, Thomas J., et al.
Publicado: (2020)

Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
por: He, Lei, et al.
Publicado: (2019)

Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
por: Wu, Arum, et al.
Publicado: (2023)

In vitro and ex vivo proteomics of Mycobacterium marinum biofilms and the development of biofilm-binding synthetic nanobodies
por: Hammarén, Milka Marjut, et al.
Publicado: (2023)

Nanobodies Selectively Binding to the Idiotype of a Dengue Virus Neutralizing Antibody Do Not Necessarily Mimic the Viral Epitope
por: Poggianella, Monica, et al.
Publicado: (2023)

Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
por: Bracken, Colton J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nqq73fvo7ko65frd3eh45ol0n1